Log in | Register

Glove Box Allows Tissue Culture And Imaging In Same Controlled Environment

For the latest pharmaceutical news and updates - Sign up now!
Loading...
Glove Box Allows Tissue Culture And Imaging In Same Controlled Environment


The COY® O2 Control Glove Box for cell growth and imaging streamlines life science laboratory operations by enabling researchers to harvest, culture, isolate, maintain and image cells while controlling temperature, humidity, CO2 and O2. The glove box design eliminates experimental error due to environmental disruption because workspace and microscope are in the same environment and cultures can go directly from incubation to the microscope. The glove box contains both a workspace for cell handling and a separate cabinet that functions as a humidified incubation box. The user's microscope sits outside the incubation box yet inside the glove box in a non-condensing environment. Oculars are readily accessible through a microscope viewport that fits into the wall of the glove box. Easy manipulation of microscope controls can be accomplished with direct contact through a unique sleeve access system that allows barehanded sample manipulation. Control ranges include temperatures of plus 4 ambient degrees C to 40°C, O2 levels of 0 percent to 60 percent with 0.1 percent resolution, and CO2 levels of 0 percent to 20 percent with 0.1 percent resolution. The glove box dehumidifier removes excess moisture from the system to create a non-condensing environment. The humidified incubation box within the glove box is saturated with the same temperature, O2 and CO2 present in the rest of the glove box.

Register or log in to send e-mail for more info

E-mail to a colleague

See company's other products

Pharmaceutical Processing

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter